Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
{{output}}
Background: Molnupiravir is being widely used as a treatment for coronavirus disease 2019 (COVID-19); however, its acceptability and safety in older patients aged ≥ 80 years in real-world clinical practice is not well understood... ...
